Viewing Study NCT05876832


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-04-15 @ 8:50 PM
Study NCT ID: NCT05876832
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-05-26
First Post: 2023-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE)
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module